VERACYTE, INC. Earnings Per Share (Diluted)
VERACYTE, INC. (VCYT) reported Earnings Per Share (Diluted) of $0.31 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-31
- VERACYTE, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $0.31.
- VERACYTE, INC. earnings per share, diluted for the quarter ending 2026-03-31 was $0.35, a 288.89% increase year-over-year.
- VERACYTE, INC. earnings per share, diluted for the quarter ending 2025-12-31 was $0.50, a 687.03% increase year-over-year.
- VERACYTE, INC. earnings per share, diluted for the quarter ending 2025-09-30 was $0.24, a 26.32% increase year-over-year.
- VERACYTE, INC. earnings per share, diluted for fiscal 2025 was $0.82, a 164.52% increase from fiscal 2024.
- VERACYTE, INC. earnings per share, diluted for fiscal 2024 was $0.31.
- VERACYTE, INC. earnings per share, diluted for fiscal 2023 was -$1.02.
- VERACYTE, INC. earnings per share, diluted for fiscal 2022 was -$0.51.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.31 10-Q · filed 2026-07-31 | $0.66 10-Q · filed 2026-07-31 | $1.16 derived: net income ÷ weighted average shares · filed 2026-07-31 | $1.41 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2026-03-31 | $0.35 10-Q · filed 2026-05-06 | $0.85 derived: net income ÷ weighted average shares · filed 2026-05-06 | $1.10 derived: net income ÷ weighted average shares · filed 2026-05-06 | $1.09 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2025-12-31 | $0.50 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.74 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.74 derived: net income ÷ weighted average shares · filed 2026-07-31 | $0.82 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.24 10-Q · filed 2025-11-05 | $0.23 derived: net income ÷ weighted average shares · filed 2026-07-31 | $0.32 10-Q · filed 2025-11-05 | $0.38 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2025-06-30 | -$0.01 10-Q · filed 2026-07-31 | $0.08 10-Q · filed 2026-07-31 | $0.14 derived: net income ÷ weighted average shares · filed 2026-07-31 | $0.33 derived: net income ÷ weighted average shares · filed 2026-07-31 |
| 2025-03-31 | $0.09 10-Q · filed 2026-05-06 | $0.15 derived: net income ÷ weighted average shares · filed 2026-05-06 | $0.34 derived: net income ÷ weighted average shares · filed 2026-05-06 | $0.42 derived: net income ÷ weighted average shares · filed 2026-05-06 |
| 2024-12-31 | $0.06 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.25 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.33 derived: net income ÷ weighted average shares · filed 2026-02-26 | $0.31 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.19 10-Q · filed 2025-11-05 | $0.27 derived: net income ÷ weighted average shares · filed 2025-11-05 | $0.25 10-Q · filed 2025-11-05 | -$0.12 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-06-30 | $0.07 10-Q · filed 2025-08-07 | $0.05 10-Q · filed 2025-08-07 | -$0.33 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-03-31 | -$0.02 10-Q · filed 2025-05-08 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.81 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2023-12-31 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.02 10-K · filed 2026-02-26 |
| 2023-09-30 | -$0.41 10-Q · filed 2024-11-07 | -$0.52 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$0.64 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$0.12 10-Q · filed 2024-08-07 | -$0.23 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$0.11 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$0.51 10-K · filed 2025-02-28 | |||
| 2022-09-30 | -$0.12 10-Q · filed 2023-11-08 | -$0.46 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | -$0.13 10-Q · filed 2023-08-09 | -$0.34 10-Q · filed 2023-08-09 | ||
| 2022-03-31 | -$0.20 10-Q · filed 2023-05-05 | |||
| 2021-12-31 | -$1.11 10-K · filed 2024-02-29 | |||
| 2021-09-30 | -$0.20 10-Q · filed 2022-11-03 | -$0.97 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$0.13 10-Q · filed 2022-08-03 | -$0.78 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | -$0.66 10-Q · filed 2022-05-04 | |||
| 2020-12-31 | -$0.66 10-K · filed 2023-03-01 | |||
| 2020-09-30 | -$0.08 10-Q · filed 2021-11-09 | -$0.52 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | -$0.22 10-Q · filed 2021-07-29 | -$0.45 10-Q · filed 2021-07-29 | ||
| 2019-12-31 | -$0.27 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |